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Interleukin-6 (IL-6) is produced in granulosa cells under normal physiological conditions, including
during ovulation. However, the roles of IL-6 in ovarian function, including regulation of LH re-
ceptor (LHR) expression in granulosa cells, have not been explored in detail. The aim of this study
was to identify themechanismunderlying theeffect of IL-6onLHRexpression in thegranulosa cells
of femaleWistar rats. Our results indicated that IL-6 clearly enhanced the FSH-induced LHRmRNA
expression in a dose-dependent manner and did not stimulate cAMP accumulation by itself. The
membrane protein level of LHR, assessed by a binding assay, was increased by FSH andwas further
enhancedby associationwith IL-6. Results of the luciferase assay, using promoter constructs of LHR
281 bp upstream of the translational start site, revealed that IL-6 increased promoter activity
induced by FSH, but this effect was not observed with treatment by IL-6 alone. This ability of IL-6
to enhance FSH-induced LHRmRNA expressionwas blocked by the JAK pathway inhibitor, but not
by the ERK1/2 inhibitor. Thus, we speculated that this IL-6 activity might be mediated by the
JAK/STAT pathway. Additionally, IL-6 augmented FSH-induced IL-6R mRNA expression and FSH
elevated IL-6 production in granulosa cells, which indicates that IL-6 may positively regulate para-
crine and autocrine actions in granulosa cells. These results suggest that IL-6 up-regulates FSH-
inducedLHRproductionby increasingmRNAtranscription, and JAK/STAT3 signaling is required for
up-regulation by IL-6 in granulosa cells.
Pituitary gonadotropins are key hormones in the regu-lation of ovarian follicles. Both LH and FSH act
through stimulatory G protein-coupled receptors and pri-
marily transduce their signals through activation of ad-
enylyl cyclase and the production of cAMP (1). The ex-
pression of LHR is one of the major markers of FSH-
induced differentiation of granulosa cells. Primary
cultures of rat granulosa cells obtained from immature
female rats pretreated with estradiol are a frequently used
model for studying granulosa cell differentiation. Expo-
sure to FSH or compounds that increase the levels of in-
tracellular cAMP results in a dose-dependent increase in
the expression of LHR in cultured granulosa cells (2). In
addition to FSH, many local factors, including cytokines,
are involved in the regulation of LHR expression (3, 4).
Since LHR play a key role in follicular maturation, ovu-
lation and steroidogenesis (5–7), elucidating the effect of
local factors on LHR expression is important for under-
standing the reproductive mechanisms in the ovary.
Interleukin-6 is a cytokine originally identified as a B
cell differentiation factor (8) and is a representative cyto-
kine producing pleiotropic effects on various cell types (9).
IL-6 binds with a transmembrane receptor, IL-6 receptor
 (IL-6R), or soluble IL-6R (sIL-6R), and binding of IL-6
to IL-6R induces heterodimerization with its coreceptor
gp130 (10). Although gp130 is expressed ubiquitously in
many organs (11), IL-6R is mainly expressed in hepato-
cytes and leukocytes (12), as well as in granulosa cells (13,
14). The dimerized gp130 triggers activation of Janus Ki-
nases (JAKs)which in turn phosphorylate the signal trans-
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ducer and activator of transcription-3 (STAT3) (10). En-
gagement of gp130 also recruits Src homology domain-
containing protein tyrosine phosphatase –2(SHP-2),
leading to activation of the ERK/MAPK cascade (10).
Under normal physiological conditions (eg, during
ovulation), IL-6 is produced in granulosa cells (15), but
studies have suggested that IL-6 negatively affects repro-
ductive functions in the ovary. For example, several re-
ports have shown that IL-6 suppresses FSH-induced es-
tradiol and progesterone in granulosa cells (16–18). The
inhibitory effects of IL-6 on gonadotropin receptor have
also been described (19, 20). Conversely, IL-6 also per-
forms important physiological functions in the ovary, act-
ing as a potent autocrine regulator of ovarian cumulus cell
function, COC expansion, and oocyte competence (21).
Therefore, the roles of IL-6 in ovarian function remain to
be elucidated.
In the present study, we examined the effect of IL-6 on
FSH-induced LH-R mRNA and protein expression levels
and mechanisms of regulation in rat primary granulosa
cells. Our results indicated that IL-6 increased FSH-in-
duced expression of LHR, which is mediated by the JAK/
STAT pathway.
Materials and Methods
Hormones and reagents
Recombinant human FSHwas supplied byDr. A. Parlow and
the National Hormone and Pituitary Program (National Insti-
tute of Diabetes and Digestive and Kidney Disease, National
Institutes of Health [NIH]). DMEM/Ham’s nutrient mixture
F-12, diethylstilbestrol (DES), and 8-bromo-cAMP (8-Br-
cAMP) were purchased from Sigma Chemical Co. (St. Louis,
MO,USA).Recombinanthuman IL-6waspurchased fromR&D
Systems, Inc. (Minneapolis,MN,USA). U0126 and Janus kinase
(JAK) inhibitor I were obtained fromCalbiochem (La Jolla, CA,
USA). Gentamicin sulfate and fungizone were purchased from
Invitrogen Corp. (Carlsbad, CA, USA). The RNA labeling kit
and nucleic acid detection kit were purchased from Roche Di-
agnostics (Indianapolis, IN, USA).
Animals
Immature female Wistar rats (Japan SLC, Inc.) were main-
tained at all times according to the NIH guidelines for the care
and use of laboratory animals and the policies of the Gunma
University Animal Care and Use Committee. Animals were
housed in a temperature-and light-controlled room (12 hours
light, 12 hours dark cycle; lights on at 0600)with food andwater
provided ad libitum.
Granulosa cell cultures
Granulosa cells were obtained from immature female Wistar
rats injected daily for 4 days with 2 mg DES in 0.2 mL of sesame
oil. The ovaries were then excised, and the granulosa cells were
released by puncturing the follicleswith 26-gauge needles.Gran-
ulosa cells were washed and collected by brief centrifugation,
and the cell viability was determined by trypan blue exclusion.
The granulosa cells were then cultured in DMEM/Ham’s nutri-
entmixture F-12 supplementedwith20mg/L gentamicin sulfate,
500 g/L fungizone, and 1 g/L BSA on collagen-coated plates in
a humidified atmosphere under 5% CO2 at 37°C.
RNA isolation and northern blot analysis
Granulosa cells were cultured in 60-mm dishes containing
5  106 viable cells in 5 mL of medium, and the reagents were
added to themediumafter 24hoursof cell culture.Thegranulosa
cellswere further incubated, and the cultureswere stopped at the
selected times as indicatedbyusing totalRNAextraction reagent
Isogen (Nippon Gene, Toyama, Japan). The final RNA pellet
was dissolved in diethylpyrocarbonate-treatedH2O.Total RNA
was quantified by measuring the absorbance of samples at 260
nm.For the northernblot analysis, 15gof totalRNAfromeach
dish were separated by electrophoresis on denaturing agarose
gels and subsequently transferred to a nylon membrane (Bio-
dyne; Pall Corp., Pensacola, FL). Rat LHR cDNAwas prepared
as described previously and linearized with BglII (22). Digoxi-
genin-labeled LHR cRNA probes corresponding to bases 440–
2560 were produced by in vitro transcription with T3 RNA
polymerase and an RNA labeling kit (Roche Diagnostics). A
digoxigenin-labeled glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) probe was obtained by the same method. In ac-
cordance with the standard protocol for the nucleic acid detec-
tionkit (RocheDiagnostics, Tokyo, Japan), themembraneswere
then exposed on Kodak XAR film (Eastman Kodak Co., Roch-
ester, NY).
Reverse transcription and quantitative RT-PCR
Isolated RNAs (2 g of each sample) from the granulosa cell
cultures were treated with DNaseI (Invitrogen) to eliminate re-
sidual genomicDNA.TheseRNAswere reverse transcribedwith
randomprimers, 10mMdeoxynucleoside triphosphatemix, and
SuperScript III reverse transcriptase (Invitrogen) according to the
manufacturer’s protocol. The reactions were incubated for 5
minutes at 25°C, 60minutes at 50°C, and 15minutes at 70°C in
a thermal cycler. To remove complementary RNA (cRNA),
RNaseHwas added to the cDNAs and incubated for 20minutes
at 37°C. Real-time RT-PCRwas performed using TaqMan gene
Expression assays (luteinizing hormone (LH)/choriogonadotro-
pin receptor: Rn00564309_m1, Eukaryotic 18s rRNA:
Hs99999901_s1 as an internal control; Applied Biosystems),
completed according to manufacturer instructions. Relative
quantificationsofmRNAwere carriedoutusing the comparative
threshold (CT) cycle method. For each sample, we normalized
the geneCTvalue using the formulaCTCTgene-CT18S. For
relative expression levels, the following formula was used:
CTCT sample-CT calibrator. This value was then used
to plot gene expression employing the formula 2-CT. The in-
terleukin-6 receptor (Rn00566707_m1) expression level was
measured in the same way as in the LHR mRNA assays.
Receptor binding assay
Granulosa cells were cultured in 24-well plates containing
5  105 viable cells in 0.5 mL of medium. After 24 hours incu-
bation, reagents were added to the medium for 72 hours. There-
after, the cells were placed on ice and quicklywashed three times
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with 0.4 mL cold medium. Then, the granulosa cells were incu-
bated in a 1:1 (vol/vol) mixture of DMEM-Ham’s F-12 medium
containing 0.1% BSA (pH 7.4) at 37°C with 1.5  105 cpm
[125I]hCG (5 ng, 30,000 cpm/ng). The hCG was iodinated ac-
cording to the chloramine-T method (23). The incubation me-
diumwas removed after 1 hour of incubation, and the cells were
washed twice with 0.4 mL of medium. The amount of radioac-
tivity remaining in thewell (cell-boundhormone)was thenquan-
tified by -spectrometry. Nonspecific binding was determined
by adding excess unlabeled hCG (50 IU/well).
Luciferase reporter assay
Plasmid pGL3-basic is a luciferase vector lacking the eukary-
otic promoter and enhancer sequences (Promega Corp., Madi-
son,WI). The PGL3-control contains a simian virus 40promoter
and a simian virus 40 enhancer inserted into the structure of
pGL3-basic (Promega). The fragment of the 5-flanking region
from bp –281 to bp –1 (relative to the translational initiation
site), which included the transcriptional regulating region of the
rat LHR,was kindly provided byDr. KaoruMiyamoto (Depart-
ment of Biochemistry, University of Fukui, Fukui, Japan) gen-
erated from the gDNA as described previously (24). To evaluate
promoter activity, these fragments were ligated to a luciferase
reporter vector (pGL3-basic) and designated LH-R(281)-Luc.
Using FuGENE 6 reagent (Promega), we transfected 300 ng of
plasmid DNA into the primary rat granulosa cell culture plates
(1.5 105 cells per 0.5mLofmedium in a 24-well culture plate).
To assay the regulatory elements, the granulosa cells were cul-
tured for 24 hours in a hormone-free medium before transfec-
tion. Twenty-four hours after transfection, the cells were treated
with hormones for 3 hours. The cells were then harvested, and
the luciferase activity was measured. The luciferase assay was
performed using the dual-luciferase reporter system (Promega),
in which the transfection efficiency was monitored by cotrans-
fected pRL-CMV-Rluc, an expression vector of Renilla
luciferase.
SDS-PAGE and western blot analysis
Granulosa cells were cultured in 60-mm dishes containing
5 106 viable cells in 5mLofmedium. Twenty-four hours later,
the cells were incubated with or without inhibitors for 1 hour at
37°C, and then stimulated with FSH plus IL-6. The cells were
lysed with RIPA buffer (pH 7.4, 150 mMNaCl, 50 mM Tris, 1
mMEDTA, 1%NP-40, 0.5% sodiumdeoxycholate, 0.1%SDS,
protease complete inhibitor). The lysate (20 g) was then re-
solved on 7.5%–12% sodium dodecyl sulfate gels and electro-
phoretically transferred to a polyvinylidene difluoride (PVDF)
membrane. After blocking, expressions of the different proteins
were determined overnight at 4°Cwith the following antibodies:
rabbit anti-phospho-p44/42MAPK (ERK1/2) (Cell Signaling
Technology; Beverly, MA, USA; no. 9101, 1:5000), rabbit anti-
p44/42 MAPK(ERK1/2) (Cell Signaling Technology; no. 9102,
1:2500), rabbit anti-phospho-STAT3 (Cell Signaling Technol-
ogy; no. 9131, 1:2500), and rabbit anti-STAT3 (Cell Signaling
Technology; no. 9132, 1:2500). After washing in TBS/T, the
membranes were incubated at room temperature for 60minutes
with horseradish peroxidase-conjugated goat antirabbit immu-
noglobulin G (IgG) antibody (Bio-Rad Laboratories, Hercules,
CA, USA; no. 170–6515, 1:40000). The proteins were finally
visualized using enhanced chemiluminescence (Immobilon
Western; Millipore, Billerica, MA, USA). Luminescence was
quantified by scanning the films with a CCD camera and ana-
lyzing the digitized data with the NIH Image 1.60 computer
program.
Data Analysis
Data represented the means SEM from at least three inde-
pendent experiments. Comparisons between groups were per-
formed by one-way ANOVA. The significance of the differences
between the mean values of the control group and each treated
group was determined using the Scheffe multiple-comparison
test. A value of P  .05 was considered significant.
Results
IL-6 enhanced the activity of FSH on expression of
LHR
To investigate the effect of FSH and IL-6 on LHR
mRNA expression, we analyzed the LHR mRNA in the
primary rat granulosa cell culture. Granulosa cells were
cultured for 24 hours after plating on a cell culture dish,
and then the cells were cultured in the absence or presence
of FSH(30 ng/mL) with or without increasing concentra-
tions of IL-6 (0.1–10 ng/mL) for 72 hours (Figure 1A).
Levels of basal LHRmRNAwere negligible and remained
unchanged by treatment with IL-6 alone. In contrast,
treatment with FSH produced an expected substantial in-
crease in LHR mRNA levels, and concurrent treatment
with increasing concentrations of IL-6 resulted in dose-
dependent increases in FSH-induced LHR mRNA.
Granulosa cells were also cultured for 24–96 hours in
the presence of FSH (30 ng/mL) with or without IL-6 at a
concentration of 10 ng/mL (Figures 1B, C). Basal LHR
mRNA levels remained low throughout the 96 hours in-
cubation period and the levels were not significantly af-
fected by treatment with IL-6 alone (data not shown). The
concurrent treatmentwith IL-6 resulted in significant aug-
mentationof theFSH-inducedLHRmRNAfrom48hours
until 96 hours.
It is known that the action of FSH ismediated by cAMP
and that a considerable amount of cAMP accumulates in
granulosa cells following FSH. It has also been shown that
FSH increases intracellular cAMP levels (25, 26); how-
ever, IL-6, either alone or in combination with FSH, had
no effect on the intracellular cAMP levels (Supplemental
Figure 1). We therefore examined the effect of IL-6 on the
expression of 8-Br-cAMP-induced LHR mRNA (Figure
1D). Treatment with 8-Br-cAMP (1–2 mM) plus IL-6 (10
ng/mL) for 72 hours produced a significant increase in
LHR mRNA, suggesting that IL-6 activated the action of
FSH at sites distal to cAMP generation in granulosa cells.
To measure the effect of IL-6 on membrane LHR pro-
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tein levels, 125I-hCG binding assay was performed (Figure
2). Granulosa cells were cultured in the absence or pres-
ence of FSH (30 ng/mL) with or without IL-6 (10 ng/mL)
for 72 hours. Basal-specific LHbindingwas negligible and
remained unchanged in response to treatment with IL-6
alone, whereas treatment with FSH produced, as ex-
pected, a substantial increase in specific LH binding, and
concurrent treatment with IL-6 produced greater change
compared with that produced by FSH alone.
IL-6 enhances the activity of FSH on IL-6R mRNA
expression
IL-6R has also been detected on the surface of gran-
ulosa cells (13, 14). In order to examine the possible effect
of FSH and IL-6 on IL-6RmRNA expression, granulosa
cellswere cultured for 24–96 hours in the presence of FSH
(30 ng/mL) with or without IL-6 at a concentration of 10
ng/mL (Figure 3). FSH increased IL-6RmRNA, and con-
current treatment with IL-6 resulted in significant aug-
mentation of the FSH-induced IL-6R mRNA from 24
hours until 48 hours.
IL-6 enhances FSH-induced activity of the LHR
promoter
To understand themechanism throughwhich FSH and
IL-6 stimulation induce LHR expression, we next inves-
tigated the effect of LHR promoter activity using IL-6. In
Figure 1. Effects of IL-6 on LHR mRNA expression in rat granulosa
cells. (A) Granulosa cells from DES-primed immature rats were cultured
for 24 hours. These cells were then further incubated with FSH (30 ng/
mL) alone or with FSH plus increasing concentration of IL-6 for 72
hours. Levels of LHR mRNA were measured by quantitative RT-PCR
using TaqMan primers. The amount of LHR mRNA with FSH alone was
taken as a ratio of 1. Data in the bar graphs represent the means 
SEM of four independent experiments. * indicates increase from the
control (FSH alone) value, P  .05; ** indicates increase from the
control value, P  .01. (B, C) Granulosa cells from DES-primed
immature rats were cultured for 24 hours. These cells were then
further incubated with FSH (30 ng/mL) alone or with FSH plus IL-6 (10
ng/mL) for 24–96 hours. The northern blot is representative of three
experiments. Levels of LHR mRNA were measured by quantitative RT-
PCR using TaqMan primers. The amount of LHR mRNA in FSH alone at
24 hours was taken as a ratio of 1. Data in the bar graphs represent
the means  SEM of three independent experiments. * indicates
increase from the control (FSH alone) value of the respective phase,
P  .05. (D) Granulosa cells from DES-primed immature rats, cultured
for 24 hours, then incubated with 8-Br-cAMP (1 or 2 mM) alone or
Legend to Figure Continued. . .
with 8-Br-cAMP plus IL-6 (10 ng/mL) for 72 hours. Levels of LHR mRNA
were measured by quantitative RT-PCR using TaqMan primers. The
amount of LHR mRNA with 8-Br-cAMP alone (1 mM) was taken as a
ratio of 1. Data in the bar graphs represent the means  SEM of three
independent experiments. ** indicates increase from the 8-Br-cAMP
alone (1 mM) value, P  .01. * indicates increase from the 8-Br-cAMP
alone (2 mM) value, P  .05.
Figure 2. Effect of IL-6 on FSH-induced LHR in rat granulosa cells.
Granulosa cells from DES-primed immature rats were cultured for 24
hours. These cells were then further incubated with FSH (30 ng/mL)
alone or with FSH plus IL-6 (10 ng/mL). After 72 hours, the levels of
LHR were determined by 125I-hCG binding assays. Data in the bar
graphs represent the means  SEM of three independent experiments.
* indicates increase from the FSH alone value, P  .01.
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aprevious experiment,Yoshino et al (24) reported that the
LHR 5-flanking region between –171 and –137 bp is es-
sential for basal expression of LHR gene. Therefore, we
selected the proximal 281 bp of the LHR 5-flanking re-
gion for this experiment.Granulosa cells transiently trans-
fected with luciferase-reporting plasmids [LH-R(281)-
Luc] responded to FSH (30 ng/mL) with significantly
enhanced activity. Moreover, treatment with IL-6 (10 ng/
mL) enhanced the FSH-induced activity of the LHR pro-
moter. However, treatment with IL-6 alone did not influ-
ence the activity of the LHR promoter (Figure 4).
Transcription stability analysis using actinomycin-D was
then performed to assess the rate of degeneration of LHR
mRNA transcripts, but no significant differenceswere ob-
served between the half-lives of LHR mRNA from FSH
alone and FSH plus IL-6 (Supplemental Figure 2).
FSH combined with IL-6 induced phosphorylation
of ERK1/2 and STAT3, and inhibitors of these
signals selectively suppressed each of these
pathways
It was previously reported that IL-6 can activate both
the ERK1/2 and STAT3pathways (10), while ERK1/2 can
be stimulated by FSH alone (27). To confirm these re-
sponses in rat granulosa cells, time course studies of west-
ern blot were performed. Western blot analysis revealed
that phosphorylation of ERK1/2 was maximal after 15
minutes exposure of IL-6, FSH, and FSH  IL-6. On the
other hand, phosphorylation of STAT3was alsomaximal
after 15 minutes exposure of IL-6 and FSH  IL-6,
whereasFSHdidnot activate theSTAT3pathway (Figures
5A, B, C,D, E, and F). At this same time point, we assessed
the selectivity of two inhibitors (U0126; inhibitor of the
upstreamERK-activating kinaseMEK, and JAK Inhibitor
I: inhibitor of JAK1/2/3) by measuring ERK1/2 and
STAT3 phosphorylation. Granulosa cells were pretreated
for1hourwithU0126 (1M)or JAK inhibitor I (0.1M),
and the phosphorylation of ERK1/2 or STAT3 was then
measuredat the endof a15-minute incubationperiodwith
FSH (30 ng/mL) plus IL-6 (10 ng/mL). From Figures 5G
and 5I (ERK1/2), and Figures 5H and 5J (STAT3), it can
be seen that U0126 significantly inhibited ERK1/2 phos-
phorylation without affecting STAT3 phosphorylation,
whereas JAK Inhibitor I inhibited STAT3 phosphoryla-
tion without affecting ERK1/2 phosphorylation.
The effect of IL-6 on up-regulation of LHR mRNA
was mediated by the STAT3 pathway
To identify the signal pathways involved in up-regula-
tion of LHR mRNA by IL-6, we analyzed the expression
of LHR mRNA in the absence or presence of U0126 or
JAK Inhibitor I.Granulosa cellswere pretreated for 1hour
with U0126 (1 M) or JAK inhibitor I (0.1 M), and the
cells were then cultured for 72 hours in the presence of
FSH (30 ng/mL) with IL-6 (10 ng/mL) (Figure 6). JAK
Inhibitor I was observed to significantly reduce LHR
mRNAexpression induced by FSH IL-6, but U0126 did
not. These results demonstrated that JAK/STAT is an im-
portantpathway throughwhich IL-6affects up-regulation
of LHR mRNA.
Discussion
In the present study, we have shown for the first time that
IL-6 enhanced the expression of FSH-induced LHR and
Figure 3. Time course of IL-6 effect on FSH-induced IL-6R mRNA.
Granulosa cells from DES-primed immature rats were cultured for 24
hours. These cells were then further incubated with FSH (30 ng/mL)
alone or with FSH plus IL-6 (10 ng/mL). Levels of IL-6R mRNA were
measured by quantitative RT-PCR using TaqMan primers. The amount
of IL-6R mRNA in FSH alone at 0 hours was taken as a ratio of 1.
Data in the bar graphs represent the means  SEM of three
independent experiments. * indicates increase from the control (FSH
alone) value of the respective phase, P  .05.
Figure 4. Effects of FSH and IL-6 on LH-R-Luc expression in rat
granulosa cells. Granulosa cells from DES-primed immature rats were
cultured for 24 hours under hormone-free conditions and then
cotransfected with LH-R(281)-Luc and pRL-CMV-Rluc. Twenty-four
hours after transfection, cells were treated with FSH (30 ng/mL) alone
or with IL-6 (10 ng/mL) for 3 hours, and then cells were lysed and
assayed for luciferase activity. Luciferase activities were corrected for
the amount of Renilla luciferase activity detected in each lysate. The
luciferase activity of the sample treated with no reagent was taken as
100%. Data in the bar graph represents the mean  SEM of the three
independent experiments. Letters a, b and c represent significant
differences (P  .01) between them.
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did not stimulate accumulation of cAMP by itself in im-
mature rat granulosa cells. We have also demonstrated
that in granulosa cells, IL-6 up-regulates FSH-induced
LHR expression via the JAK/STAT signal transduction
pathway.
In the ovary, a variety of cytokines plays important
roles in the control of ovarian functions. The most well-
known cytokines related to reproduction are interleukins,
colony stimulating factors (CSFs), and interferons (IFNs)
(28). In our initial investigation of the effect of IL-6 on
LHR mRNA expression, the protein level of LHR was
assessed by binding assay and was found to increase in
response to FSH, and this increase was further enhanced
by association with IL-6 (Figure 2).
Our data were also consistent with
results indicating that changes in the
number of cell-surface LH receptors
are closely paralleled by changes in
LH receptor mRNA levels (29).
We also investigated whether the
regulation of LHR mRNA by FSH
and IL-6 was dependent on gene
transcription and/or receptor
mRNA stability. Yoshino et al (24)
reported that the 5-flanking region
of Lhcgr between –171 and –137 bp
is essential forbasal expressionof the
Lhcgr gene in rat granulosa cells. It
has also been reported that the three
Sp-1 binding sites, located at –83,-
103,-143 bp of the upstream region
and within the proximal portion of
the 5-flanking region, appear to be
important for LHR transcription in
rat granulosa cells (30). Therefore,
wemeasured luciferase activityusing
promoter constructs of LHR con-
taining281bpupstreamof the trans-
lational start site. The luciferase as-
say showed that FSH significantly
enhanced the activity of the 281 bp
LHR 5-flanking region, and that
treatment with IL-6 alone did not in-
fluence the activity of the LHR pro-
moter, but increased promoter activ-
ity inducedbyFSH(Figure4).On the
other hand, IL-6 did not appear to
influence FSH-induced LHRmRNA
stability (Supplemental Figure 2).
These data demonstrated that IL-6
increases promoter activity of LHR
induced by FSH, but does not influ-
ence LHR mRNA stability.
Under normal physiological con-
dition, such as during ovulation,
IL-6 is produced in granulosa cells
(15). The receptor for IL-6 is com-
posed of an IL-6 subunit and
gp130, and IL-6 binding produces
Figure 5. (A, B, C, D, E, F) Effects of IL-6 and/or FSH on phosphorylation of ERK and STAT3 in
rat granulosa cells. Granulosa cells from DES-primed immature rats were cultured 24 hours, and
then treated for the indicated times with IL-6 (10 ng/mL) and/or FSH (30 ng/mL). Whole cell
lysates were used for western blot to detect levels of phosphorylated ERK(p-ERK) (A, C, and E),
and phosphorylated STAT3 (p-STAT3) (B, D, and F). The detection of ERK1/2 or STAT3 protein
served as a loading control. The blot is representative of three independent experiments. (G, H, I,
J) Effects of pathway blockade in FSH plus IL-6-induced phosphorylation of ERK and STAT3 in rat
granulosa cells. Granulosa cells from DES-primed immature rats were cultured 24 hours. These
cells were pretreated with MEK inhibitor U0126 (1 M) or JAK1/2/3 inhibitor JAK Inhibitor I (0.1
M) for 1 hour. Cells were then treated for 15 minutes with FSH (30 ng/mL) plus IL-6 (10 ng/mL).
Whole cell lysates were used for western blot to detect levels of phosphorylated ERK(p-ERK) (G),
and phosphorylated STAT3 (p-STAT3) (H). The detection of ERK1/2 or STAT3 protein served as a
loading control. The blot is representative of three independent experiments. Relative ratios of
phosphorylated proteins to total proteins were quantified by scanning the films obtained from
western blotting, and digitized data were analyzed with the NIH Image 1.60 software program (I,
J). The digitized data of untreated groups were taken as a ratio of 1. The absorbance values in
the bar graphs represent the means  SEM of three independent experiments. * indicates
decrease from FSH plus IL-6 value, P  .01.
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the gp130 homodimer, which activates Janus kinases
(JAKs) and subsequently phosphorylates the signal trans-
ducer and activator of transcription-3 (STAT3) (10). En-
gagement of gp130 also recruits the signal-transducing
molecule Src homology domain-containing protein ty-
rosine phosphatase-2 (SHP-2), which leads to activation
of the ERK/MAPK cascade (10). In addition to IL-6, IL-
6Rwas also detected on the surface of human granulosa
cells (13, 14). As seen in Figure 3, FSH increased IL-6R
mRNA, while concurrent treatment with IL-6 resulted in
significant augmentation of FSH-induced IL-6RmRNA
expression. It has been reported that FSH elevates IL-6
release from granulosa cells through cAMP-dependent
mechanisms (31). Although these data indicate the posi-
tive paracrine and/or autocrine regulationof IL-6 action in
granulosa cells, it is possible that the immune cells in the
ovary contribute to the product of IL-6, which would be
consistent with several studies suggesting that IL-6 is pro-
duced by immune cells such as T-cells, B-cells, monocytes
(10, 12).
Conversely, other studies have suggested that IL-6may
adversely influence ovarian functions. For example, IL-6
reportedly suppressed FSH-induced production of estra-
diol and progesterone in granulosa cells (16–18). In con-
trast to our study, the inhibitory action of IL-6 on the
expression of FSH induced LHR mRNA has also been
reported (20). This difference between result of this pre-
vious study and our current study might be attributed to
variations in in vivo hormonal treatment prior to primary
cell culturing and/or the in vitro culture system, itself. Fol-
lowing diethylstibestrol (DES) treatment in our experi-
ment, granulosa cells expressed FSH receptors but not LH
receptors (32, 33), while PMSG treatment resulted in the
expressionofbothLHandFSHreceptors in culturedgran-
ulosa cells in the absence of hormone treatment (20, 33) .
We confirmed that IL-6 stimulated the phosphoryla-
tion of both ERK1/2 and STAT3, while FSH stimulated
ERK1/2 alone in rat granulosa cells (Figures 5A, B, C, and
D). At the same time, we determined that treatment com-
bining FSH and IL-6 stimulated both ERK1/2 and STAT3
phosphorylation (Figures 5E, and F). We also identified
conditions to selectively inhibit ERK1/2 and STAT3 path-
ways (Figures 5G,H, I, and J). To identify the signal trans-
duction pathway involved in activation of FSH and its
effect on LHR expression by IL-6, we investigated the
effect of IL-6 onFSH-inducedLHRmRNA,usingERK1/2
and JAK inhibitors. The JAK pathway inhibitor blocked
the effects of IL-6 on FSH action for LHRmRNA expres-
sion, but the ERK1/2 pathway inhibitor produced no sig-
nificant effect (Figure 6). Therefore, we speculated that
IL-6 activity might be mediated by the JAK/STAT
pathway.[2
In terms of the effects of FSH on granulosa cell differ-
entiation, cAMP-dependent protein kinase A (PKA) me-
diates most of the action of FSH (34, 35). In addition, the
expression of FSH-stimulated LHR mRNA is dependent
on the PKA pathway in granulosa cells (36). The activa-
tion of PKA results in the phosphorylation of certain tran-
scription factors that bindwith cAMP-responsive element
(CRE) to induce or repress the expression of FSH-respon-
sive genes. These cAMP responsive factors are known as
cAMP-response element-binding proteins (CREB). Previ-
ous studies have reported that, although a classical CRE is
not present in the 5-flanking region of Lhcgr (37), the
Lhcgr gene promoter region forms a complex that in-
creases significantly following pretreatment with 8Br-
cAMP, and is essential for cAMP responsiveness of the rat
Lhcgr gene (30). Therefore, we speculated that IL-6 in-
ducible transcription factormight interactwith the factors
induced by FSHand subsequently enhance transcriptional
activity on the 5-flanking region of the Lhcgr gene. Our
results indicated that IL-6 alone does not change the
amount of LHRmRNA, but it is effective when combined
with FSH action. These data indicate that themechanisms
of IL-6-induced JAK/STAT phosphorylation, which en-
hance LHR mRNA expression, do not represent a direct
effect, but instead involve activation of a component
downstream of the PKA pathway. Additionally, another
study indicated that STAT5-independent nuclear JAK2
signaling plays an essential role in adrenal steroidogenesis
by increasing stability of the transcriptionally active
CREB (38). It is therefore possible that IL-6 may enhance
the expression of LHR mRNA through a similar
mechanism.
Figure 6. Effects of ERK and JAK/STAT inhibition on LHR mRNA
expression in rat granulosa cells. Granulosa cells from DES-primed
immature rats were cultured for 24 hours. These cells were pretreated
with MEK inhibitor U0126 (1 M) or JAK1/2/3 inhibitor JAK Inhibitor I
(0.1 M) for 1 hour. Cells were then treated for 72 hours with FSH (30
ng/mL) alone or with FSH plus IL-6 (10 ng/mL). LHR mRNA levels were
measured by quantitative RT-PCR using TaqMan primers. The amount
of LHR mRNA with FSH alone was taken as a ratio of 1. Data in the bar
graphs represent the means  SEM of five independent experiments.
For each treatment, statistically significant differences in mRNA
expression are indicated with asterisks (*P  .01).
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It has also been reported that the JAK/STAT pathway
is active in granulosa cells. Leptin suppresses anti-Mulle-
rian hormone (AMH) mRNA through the JAK2/STAT3
pathway in granulosa cells of women undergoing IVF
(39). Additionally, prolactin (PRL) up-regulates the ex-
pression of endogenous bone morphogenetic protein-
(BMP) and Smad1/5/8 signaling activity by inhibiting
Smad6 expression via the JAK/STAT pathways, which
leads to suppression of PRL receptor signaling in rat gran-
ulosa cells (40). In COC, the JAK/STAT pathway modu-
lates the expression of key COC expansion related genes,
such asHas2, Ptgs2, Tnfaip6, and Ptx3 (21). Our results,
togetherwith those fromprevious reports, suggest that the
JAK/STAT pathway plays an important role in normal
ovarian function, including the expression of LHR.
Since a number of previous studies have repeatedly em-
phasized that IL-6 negatively affects steroidogenesis, the
presence of IL-6 was assumed to be of pathophysiological
relevance. However, IL-6 may induce LHR mRNA in the
presence of FSH activation, and this may have important
physiological effects on follicular growth. On the other
hand, since many other factors are reported as essential
local factors of follicular growth, the relationship between
IL-6 and these other factors remains to be clarified.
In this study,we demonstrated that IL-6 increases FSH-
induced expression of LHR and LHRmRNAby enhance-
ment of gene transcription in rat granulosa cells. We also
found that IL-6 activity is mediated by the JAK/STAT
pathway, and these results suggest that IL-6andFSHwork
cooperatively to regulate ovarian function.
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